Universal-Beteiligungs- und Servicegesellschaft’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$61.9K Hold
19,100
– – ﹤0.01% 2101
2026
Q1
$47.2K Buy
19,100
+6,000
+46% +$12.7K ﹤0.01% 2051
2025
Q4
$26.8K Hold
13,100
– – ﹤0.01% 2043
2025
Q3
$45.5K Hold
13,100
– – ﹤0.01% 2075
2025
Q2
$28.8K Hold
13,100
– – ﹤0.01% 1997
2025
Q1
$15.2K Buy
+13,100
New +$19.3K ﹤0.01% 1983

Other funds holding EDIT

Universal-Beteiligungs- und Servicegesellschaft's EDIT Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft held its Editas Medicine (EDIT) position steady in Q2 2026 at 19,100 shares worth $61.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2101.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in EDIT in Q1 2025 and has held it in 6 quarters since. 215 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 19,100 shares of Editas Medicine worth $61.9K as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft left its Editas Medicine share count unchanged in Q2 2026.
  • Editas Medicine made up ﹤0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #2101 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Editas Medicine in Q1 2025 and has held it in 6 quarters since.
  • 215 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.